The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma

Cancer Letters

Volumn 228, Issue 1-2, 2005, Pages 105-110

  Lovat, Penny E ^a   Corazzari, Marco ^b   Di Sano, Federica ^c   Piacentini, Mauro ^b,c   Redfern, Christopher P F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; Ceramide; Fenretinide; Gangliosides; GD2; GD3

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; FENRETINIDE; GANGLIOSIDE; GANGLIOSIDE GD2; GANGLIOSIDE GD3;

APOPTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 23944510163     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.044     Document Type: Review

References (48)

1. K.K. Matthay, J.G. Villablanca, R.C. Seeger, D.O. Stram, R.E. Harris, and N.K. Ramsay Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group N. Engl. J. Med. 341 1999 1165 1173
2. G.J. Veal, J. Errington, C.P.F. Redfern, A.D. Pearson, and A.V. Boddy Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells Biochem. Pharmacol. 63 2002 207 215
3. S. Vertuani, A. De Geer, V. Levitsky, P. Kogner, R. Kiessling, and J. Levitskaya Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes Cancer Res. 63 2003 8006 8013
4. A. Lasorella, A. Iavarone, and M.A. Israel Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance Cancer Res. 55 1995 4711 4716
5. B. Meister, F.M. Fink, A. Hittmair, C. Marth, and M. Widschwendter Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma Anticancer Res. 18 1998 1777 1786
6. B.J. Maurer, L.S. Metelitsa, R.C. Seeger, M.C. Cabot, and C.P. Reynolds Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines J. Natl Cancer Inst. 91 1999 1138 1146
7. A.L. Sabichi, M.R. Modiano, J.J. Lee, Y.M. Peng, M.J. Xu, and H. Villar Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide Clin. Cancer Res. 9 2003 2400 2405
8. A. Garaventa, R. Luksch, M.S. Lo Piccolo, E. Cavadini, P.G. Montaldo, and M.R. Pizzitola Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma Clin. Cancer Res. 9 2003 2032 2039
9. P.E. Lovat, M. Ranalli, F. Bernassola, M. Tilby, A.J. Malcolm, and A.D.J. Pearson Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs Int. J. Cancer 88 2000 977 985
10. P.E. Lovat, M. Ranalli, F. Bernassola, M. Tilby, A.J. Malcolm, and A.D.J. Pearson Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents Med. Pediatr. Oncol. 35 2000 663 668
11. P.E. Lovat, M. Ranalli, M. Annichiarrico-Petruzzelli, F. Bernassola, M. Piacentini, and A.J. Malcolm Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma Exp. Cell Res. 260 2000 50 60
12. P.E. Lovat, S. Oliverio, M. Ranalli, M. Corazzari, C. Rodolfo, and F. Bernassola GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma Cancer Res. 62 2002 5158 5167
13. P.E. Lovat, M. Ranalli, M. Corazzari, L. Raffaghello, A.D.J. Pearson, and M. Ponzoni Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma J. Cell Biochem. 89 2003 698 708
14. P.E. Lovat, S. Oliverio, M. Corazzari, C. Rodolfo, M. Ranalli, and B. Goranov Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells Cancer Res. 63 2003 7310 7313
15. Q.D. Campbell Hewson, P.E. Lovat, M. Corazzari, J.B. Catterall, C.P.F. Redfern, The NF-κB pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells, Apoptosis (in press).
16. B.J. Maurer, L. Melton, C. Billups, M.C. Cabot, and C.P. Reynolds Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl) retinamide and modulators of ceramide metabolism J. Natl Cancer Inst. 92 2000 1897 1909
17. H. Wang, A.G. Charles, A.J. Frankel, and M.C. Cabot Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells Urology 61 2003 1047 1052
18. A. Erdreich-Epstein, L.B. Tran, N.N. Bowman, H. Wang, M.C. Cabot, and D.L. Durden Ceramide signaling in fenretinide-induced endothelial cell apoptosis J. Biol. Chem. 277 2002 49531 49537
19. H. Wang, B.J. Maurer, C.P. Reynolds, and M.C. Cabot N-(4-hydroxyphenyl) retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase Cancer Res. 61 2001 5102 5105
20. Y.A. Hannun, C. Luberto, and K.M. Argraves Enzymes of sphingolipid metabolism: from modular to integrative signaling Biochemistry 40 2001 4893 4903
21. A. Colell, A. Morales, J.C Fernandez-Checa, and C. Garcia-Ruiz Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-alpha-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3 Fed. Eur. Biochem. Soc. Lett. 526 2002 135 141
22. C. Garcia-Ruiz, A. Colell, M. Mari, A. Morales, and J.C. Fernandez-Checa Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione J. Biol. Chem. 272 1997 11369 11377
23. R. De Maria, L. Lenti, F. Malisan, F. d'Agostino, B. Tomassini, and A. Zeuner Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis Science 277 1997 1652 1655
24. N. Andrieu-Abadie, and T. Levade Sphingomyelin hydrolysis during apoptosis Biochim. Biophys. Acta 1585 2002 126 134
25. E. Gulbins, and H. Grassme Ceramide and cell death receptor clustering Biochim. Biophys. Acta 1585 2002 139 145
26. H. Zhao, M. Miller, K. Pfeiffer, J.A. Buras, and G.L. Stahl Anoxia and reoxygenation of human endothelial cells decrease ceramide glucosyltransferase expression and activates caspases Fed. Am. Soc. Exp. Biol. J. 17 2003 723 724
27. A.M. DiPietrantonio, T.C. Hsieh, S.C. Olson, and J.M. Wu Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR) Int. J. Cancer 78 1998 53 61
28. P.E. Lovat, F. Di Sano, M. Corazzari, B. Fazi, R.P. Donnorso, and A.D.J. Pearson Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide J. Natl Cancer. Inst. 96 2004 1288 1299
29. T. Murate, M. Suzuki, M. Hattori, A. Takagi, T. Kojima, and T. Tanizawa Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line J. Biol. Chem. 277 2002 9936 9943
30. T. Herget, C. Esdar, S.A. Oehrlein, M. Heinrich, S. Schutze, A. Maelicke, and G. van Echten-Deckert Production of ceramides causes apoptosis during early neural differentiation in vitro J. Biol. Chem. 275 2000 30344 30354
31. K. Wiegmann, R. Schwandner, O. Krut, W.C. Yeh, T.W. Mak, and M. Kronke Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase J. Biol. Chem. 274 1999 5267 5270
32. B.J. Pettus, C.E. Chalfant, and Y.A. Hannun Ceramide in apoptosis: an overview and current perspectives Biochim. Biophys. Acta 1585 2002 114 125
33. H. Komori, S. Ichikawa, Y. Hirabayashi, and M. Ito Regulation of UDP-glucose: ceramide glucosyltransferase-1 by ceramide Fed. Eur. Biochem. Soc. Lett. 475 2000 247 250
34. H. Komori, S. Ichikawa, Y. Hirabayashi, and M. Ito Regulation of intracellular ceramide content in B16 melanoma cells. Biological implications of ceramide glycosylation J. Biol. Chem. 274 1999 8981 8987
35. S.A. Boldin, and A.H. Futerman Up-regulation of glucosylceramide synthesis upon stimulation of axonal growth by basic fibroblast growth factor. Evidence for post-translational modification of glucosylceramide synthase J. Biol. Chem. 275 2000 9905 9909
36. F. Di Sano, B. Fazi, G. Citro, P.E. Lovat, G. Cesareni, and M. Piacentini Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells Cancer Res. 63 2003 3860 3865
37. H. Sietsma, A.J. Dijkhuis, W. Kamps, and J.W. Kok Sphingolipids in neuroblastoma: their role in drug resistance mechanisms Neurochem. Res. 27 2002 665 674
38. R.J. Bleicher, and M.C. Cabot Glucosylceramide synthase and apoptosis Biochim. Biophys. Acta 1585 2002 172 178
39. F. Malisan, and R. Testi GD3 ganglioside and apoptosis Biochim. Biophys. Acta 1585 2002 179 187
40. A.K. Bhunia, G. Schwarzmann, and S. Chatterjee GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells J. Biol. Chem. 227 2002 16396 16402
41. A. Copani, D. Melchiorri, A. Caricasole, F. Martini, P. Sale, and R. Carnevale Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons J. Neurosci. 22 2002 3963 3968
42. V.V. Bezuglov, E.V. Fomina-Ageeva, N.M. Gretskaia, E.V. Kriukova, E.V. Diatlovitskaia, and L.D. Bergel'son Gangliosides modulate lipoxygenase oxidation in human lymphocytes Biokhimiia 56 1991 267 272
43. K. Mujoo, D.A. Cheresh, H.M. Yang, and R.A. Reisfeld Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth Cancer Res. 47 1987 1098 1104
44. J.L. Murray, J.E. Cunningham, H. Brewer, K. Mujoo, A.A. Zukiwski, and D.A. Podoloff Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors J. Clin. Oncol. 12 1994 184 193
45. A.L. Yu, M.M. Uttenreuther-Fischer, C.S. Huang, C.C. Tsui, S.D. Gillies, R.A. Reisfeld, and F.H. Kung Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma J. Clin. Oncol. 16 1998 2169 2180
46. B.H. Kushner, K. Kramer, and N.K. Cheung Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma J. Clin. Oncol. 19 2001 4189 4194
47. T. Simon, B. Hero, A. Faldum, R. Handgretinger, M. Schrappe, D. Niethammer, and F. Berthold Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma J. Clin. Oncol. 22 2004 3549 3557
48. M. Rebhan, G. Vacun, K. Bayreuther, and H. Rosner Altered ganglioside expression by SH-SY5Y cells upon retinoic acid-induced neuronal differentiation Neuroreport 5 1994 941 944